
Ethizone Taz 250mg/31.25mg Injection
Marketer
Human Biolife India Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Ethizone Taz 250mg/31.25mg Injection
Taz-Ethizone 250mg/31.25mg injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism halts microbial proliferation, thus limiting infection spread. Administration must be overseen by a physician. Consistent adherence to the prescribed regimen is crucial; premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, edema, respiratory distress) demand prompt medical intervention. Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness warrants driving cessation. Adequate rest, balanced nutrition, and sufficient hydration promote optimal recovery. Your physician may order tests to monitor the medication's impact.
Uses of Ethizone Taz 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ethizone Taz 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ethizone Taz 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ethizone Taz 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ethizone Taz 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Ethizone Taz 250mg/31.25mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, thereby inhibiting bacterial growth. Tazobactum, a beta-lactamase inhibitor, safeguards Ceftriaxone's effectiveness by neutralizing bacterial enzymes that would otherwise break it down.
SAFETY ADVICE
AlcoholSAFE
Ethizone Taz 250mg/31.25mg Injection does not interact negatively with alcohol consumption.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ethizone Taz 250mg/31.25mg Injection is generally deemed safe. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; clinical data in humans, however, remains scarce.
Breast feedingCAUTION
Administering Ethizone Taz 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Ethizone Taz 250mg/31.25mg Injection can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ethizone Taz 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Ethizone Taz 250mg/31.25mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage alteration for Ethizone Taz 250mg/31.25mg Injection is unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Ethizone Taz 250mg/31.25mg Injection :
Omit a dose of Ethizone Taz 250mg/31.25mg Injection? Seek medical advice immediately.
Facts to Know About Ethizone Taz 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
